Toggle navigation
Browse
Home
People
Departments & Colleges
Research
Research Area Overlaps
Arthritis & Rheumatology
Journal
Overview
Overview
publication venue for
Efficacy and safety of lenabasum, a cannabinoid type 2 receptor agonist, in a phase 3 randomized trial in diffuse cutaneous systemic sclerosis
. 75:1608.
2023
